Elizabeth B Kelso Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

3/2006

Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth B Kelso Research Topics

Disease

3	Osteoarthritis 10/2012 - 07/2010
2	Arthritis (Polyarthritis) 03/2007 - 01/2003
2	Rheumatoid Arthritis 03/2007 - 03/2006
2	Inflammation (Inflammations) 03/2006 - 01/2003
1	Synovitis 10/2012
1	Hyperemia 01/2003

Drug/Important Bio-Agent (IBA)

4	Peptide Hydrolases (Proteases)FDA Link 10/2012 - 01/2003
2	CytokinesIBA 10/2012 - 03/2007
2	Monoclonal AntibodiesIBA 11/2010 - 03/2006
1	1- 3- methylbutyryl- N4- 6- aminohexanoyl- piperazineIBA 10/2012
1	PAR-2 ReceptorIBA 11/2010
1	Serine Proteases (Serine Protease)IBA 07/2010
1	matriptaseIBA 07/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2006
1	Proteinase-Activated ReceptorsIBA 03/2006
1	2- furoyl- leucyl- isoleucyl- glycyl- lysyl- valineIBA 01/2003

Therapy/Procedure

1	Biological Therapy 03/2006
1	Therapeutics 03/2006
1	Intra-Articular Injections 01/2003